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 املضاعفات الرئوية الشديدة ملرض الربمييات
املضادات احليوية و ادوية الكورتيزون بالتبادل
جايا كر�شنان, فاطمة بن عابد, عبداهلل باخلري, جمعه الكعبي, عمر الروا�س, جوجي جورج, خلفان الزيدي
الغري موبوءة مبر�س  االماكن  انها منت�رشة, عادة ما تكت�شف يف وقت متاأخر يف  الربمييات, مع  الرئوية ملر�س  امللخ�س: امل�شاعفات 
الربمييات. هنا ندرج حالة ا�شابة مبر�س الربمييات مع م�شاعفات رئوية �شديدة يف م�شت�شفى جامعة ال�شلطان قابو�س عوجلت بامل�شادات 
احليوية املريوبنم ) واحد جرام كل ثمان �شاعات( و املوك�شيفلوك�ش�شني )400 ملي جرام مرة واحدة يف اليوم( باالإ�شافة اىل جرعات كبرية 
من ادوية الكورتيزون. ادوية الكورتيزون اأعطت ملدة ثالثة اأ�شهر لوجود التهابات رئوية م�شتمرة.
مفتاح الكلمات: مر�س الربمييات؛ االن�شان؛ متالزمة ال�شائقة التنف�شية احلادة؛ حالة مر�شية؛ �شتريويدات؛ عمان.
abstract: Pulmonary complications in leptospirosis, though common, are often unrecognized in a 
non-endemic area. We report here a patient with leptospirosis and severe pulmonary involvement who was treated 
with meropenem (1 g every 8 hours), moxifloxacin (400 mg once daily), and high doses of corticosteroids. Systemic 
steroids were continued for 3 months because of persistent pulmonary lesions.
Keywords: Leptospirosis; Human ARDS; Steroids; Case report; Oman.
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case report
Leptospirosis usually presents as a non-specific anicteric myalgic febrile illness, a benign aseptic meningitis syndrome, or an 
icteric form with severe manifestations. Pulmonary 
complications are common (20–70%).1,2 When a 
patient from a non-endemic area presents with 
pulmonary involvement without the classical 
symptoms, leptospirosis is not often suspected.3 
We present a patient with severe lung involvement 
who responded to antibiotics other than penicillin 
or doxycycline, parenteral methyl prednisone and 
ventillatory support but needed oral prednisolone 
for 3 months to achieve a complete recovery.
Case Report
A 13-year-old female presented to her regional 
hospital in Oman with a two-day history of fever, 
dry cough, and shortness of breath. She had been 
unwell for a week and had visited private clinics. 
On examination, the patient was febrile (39o C), 
tachypnoeic, and tachycardic. Blood pressure 
was normal. The chest was clear on auscultation. 
Liver and spleen were not enlarged but a few small 
cervical lymph nodes were palpable. A complete 
blood count, erythrocyte sedimentation rate and 
renal function were normal. Liver enzymes were 
slightly raised. A chest radiograph showed bilateral 
symmetrical patchy opacities uniformly distributed 
in the middle and lower zones with a peripheral 
distribution. Blood, urine, and sputum cultures did 
not grow any organisms. An autoimmune work-up 
and screening for H1N1 were both negative. Bone 
marrow and lymph node biopsies were inconclusive. 
A skin biopsy showed features of urticarial vasculitis. 
Since she did not respond to antibiotics, a diagnosis 
of miliary tuberculosis (TB) was entertained. As 
her liver functions were deranged she was started 
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on a modified anti-TB regimen with moxifloxacin, 
streptomycin, and ethambutol. 
The patient started to desaturate so was 
intubated and ventilated. A computed tomography 
(CT) scan of the chest revealed bilateral symmetrical 
interstitial infiltrates distributed predominantly in 
the middle and lower zones. A bronchoscopy did not 
reveal any abnormalities and the bronchoalveolar 
lavage (BAL) grew Klebsiella pneumoniae, for 
which meropenem was added. Sputum and BAL 
were negative for acid fast bacilli. Her haemoglobin 
and platelets came down, liver enzymes showed a 
significant rise, and the renal function started to 
decline. 
The patient was then transferred 1,000 Km 
from the regional hospital to Sultan Qaboos 
University Hospital, Muscat, a tertiary centre. Basic 
investigations showed a haemoglobin level of 8.5 g/
dl, white blood count of 9.2 x 109/L, and a platelet 
count of 68 x 109/L. Liver function was deranged 
with a serum alanine aminotransferase of 650 IU/L, 
a serum aspartate aminotransferase of 241 IU/L, 
and an alkaline phosphatase of  275 IU/L; bilirubin 
was 22 umol/L. The renal functions and c-reactive 
protein were normal. Repeated antinuclear 
antibodies, anti-neutrophil cytoplasmic antibodies, 
and anti-glomerular basement membrane 
antibodies were all negative. Complements C3 
(0.49) and C4 (0.08) were low. An echocardiogram 
was reported as normal. A chest radiograph showed 
bilateral diffuse infiltrates [Figure 1A]. The CT of 
the chest revealed bilateral symmetrical patchy 
opacities with micronodularity and intralobular 
and centrilobular septal thickening [Figure 1B].
Seronegative lupus with pulmonary involve-
ment, unexplained vasculitis, acute interstitial 
pneumonia, eosinophilic pneumonia, drug-induced 
lung disease, Pneumocystis carinii infection, and 
viral pneumonia were the immediate differential 
diagnoses. She was pulsed with 250 mg of 
 
Figure 1 A–D: (A) Chest radiograph on admission to our centre showing bilateral uniform opacities with a peripheral 
distribution; (B) Computed tomography (CT) image showing bilateral symmetrical opacities with interlobular and 
centrilobular septal thickening and micronodularities; (C) CT scan during follow-up one month after discharge showing 
persistent interstitial shadows; (D) CT scan showing total resolution of the opacities but with minimal localised interstitial 
shadows on the right side.
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methylprednisolone once daily for 3 days followed 
by oral prednisolone. Anti-TB medications were 
stopped but meropenam and moxifloxacin were 
continued. An open lung biopsy was planned, 
but because of a further drop in platelets this was 
deferred. The patient was extubated on the second 
day of pulsed steroids and was then supported with 
non-invasive ventilation (NIV). Slowly the oxygen 
requirement came down and she was weaned from 
NIV. 
This improvement was not sustained. Her chest 
radiograph showed an increase in the opacities, 
she became more dyspnoeic, and her platelets 
and haemoglobin dropped to 4 x 109/L and 7 g/
dl, respectively. The NIV was resumed and the 
prednisolone treatment was changed back to 
methylprednisolone (100 mg daily). The girl’s 
mother then told of a family picnic to the mountains 
a few days prior to the onset of her symptoms, 
stating that other members of the family had 
developed a rash and a transient febrile illness. This 
prompted us to do a work-up for a cryptic infection. 
In addition to the samples sent for Legionella, 
Mycoplasma pneumoniae, Pneumocystis carinii 
and human immunodeficiency virus (HIV) earlier, 
further samples were collected for Leptospira, 
cytomegalovirus, malarial parasite, Rickettsia, and 
haemorrhagic fevers.
Fortunately, in the next 5 days the patient 
showed definite signs of improvement and was 
transferred to the general medical ward on 3 L of 
oxygen. Almost 6 weeks after the onset of symptoms, 
the serology for leptospirosis was reported positive 
by enzyme immunoassay for genus-specific IgM 
human antibodies against Leptospira (SERION 
ELISA classic Leptospira, Institut Virion Serion 
GmbH, Würzburg, Germany) from the public health 
laboratory. Since a microscopic agglutination test 
was not available, detection of IgM antibodies was 
taken as evidence of recent infection with Leptospira 
in this clinical context. Following the report, she 
was started on doxycycline. When discharged after 
3 weeks, she was weak and had residual pulmonary 
infiltrates, but was saturating well on room air and 
could move with support. Because of the persistent 
pulmonary infiltrates, prednisolone was continued. 
When seen in the outpatient clinic one month 
later, the patient's chest was clear on auscultation, 
her SaO2 on room air was 99%, her laboratory 
investigations were back to normal, and her chest 
radiograph showed total resolution. Still, the CT 
scan showed residual linear opacities [Figure 1C] so 
the prednisolone was continued. A CT chest done 
after 3 months was normal with total resolution 
of the opacities [Figure 1D]. At that point, the 
prednisolone was discontinued.
Discussion
The first publication of lung involvement in 
leptospirosis is attributed to Moeschlin in 1943.1 
The spectrum of pulmonary manifestations is 
wide, ranging from mild respiratory symptoms 
to the presence of acute respiratory distress 
syndrome (ARDS). Cough, haemoptysis, and 
different grades of dyspnoea are the most common 
pulmonary symptoms. Chest radiographs usually 
show bilateral lower lobe involvement with a 
peripheral distribution. Nodular or reticulo- 
nodular infiltrations, consolidations, and a ground 
glass appearance are the most common patterns 
seen.4 High-resolution CT will show bilateral 
ground glass opacities involving all lobes, areas of 
consolidations,  peripheral airspace nodules, and, 
rarely, pleural effusions.5,6 Leptospirosis is not 
common in Oman and this is the first report of an 
Omani national contracting the disease without 
travelling abroad to endemic areas. Due to this, 
the diagnosis was not suspected in our patient on 
presentation.
Alveolar haemorrhage and ARDS are two 
of the most fatal conditions associated with 
leptospirosis.1,6-8 Pulmonary oedema secondary 
to myocarditis, renal failure, or over-rehydration 
during resuscitation have also been reported.1 In 
the most severe pulmonary form of leptospirosis, 
where mortality rates can be as high as 30–60%, 
respiratory symptoms usually appear between the 
4th and 6th day of disease and may lead to death in 
less than 72 hours.8,9 Although the pathogenesis of 
pulmonary manifestations is poorly understood, 
vasculitis mediated by toxins and an exaggerated 
immune response in the host are believed to 
be responsible.1,6,9 Capillary endothelial damage 
leads to different grades of interstitial and alveolar 
haemorrhage. Since the BAL findings were not 
consistent with alveolar haemorrhage, we presume 
that our patient developed acute lung injury (ALI) 
and then ARDS, possibly with an underlying 
haemorrhagic pneumonitis.
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For leptospirosis, the antibiotics treatment has 
to be started early, and supportive care with 
correction of dehydration, hypovolaemia, 
hypotension, and electrolyte abnormalities is 
essential.2 Prompt management of  renal and hepatic 
dysfunction and acute respiratory failure may 
decrease the mortality rate.1,7,10 Human leptospirosis 
is generally treated with penicillin or doxycycline, 
but these antibiotics are not used initially if the 
diagnosis is not suspected.1,11 Interestingly, a recent 
review showed that the benefit of antibiotic therapy 
in the treatment of leptospirosis, particularly for 
severe disease, remains unclear and the choice of 
penicillin, doxycycline, or cephalosporin did not 
affect mortality rates nor the duration of fever.12 As 
often happens with severe pulmonary involvement 
due to any disease, broader-spectrum antibiotics 
were started along with assisted ventilation and 
supportive care while tests were being run. Our 
patient received meropenem and moxifloxacin 
which helped tide her over the crisis, thus proving 
that these antibiotics are active against the 
species. As for the laboratory proof, Hospenthal 
and Murray, while studying the susceptibilities of 
11 serovars of Leptospira to 14 antibiotics, found 
that with the exception of chloramphenicol, all 
tested agents, including moxifloxacin, were found 
to be at least as potent as penicillin and doxycycline.13 
Although benefits of corticosteroids in ALI 
is known, evidence for use of corticosteroids in 
pulmonary leptospirosis is confined to occasional 
case reports or small studies.14,15 High doses or a 
pulse of dexamethasone or methylprednisolone 
have been used in patients with severe lung 
involvement in leptospirosis.14,16,17 In a series 
of 30 patients, Shenoy et al. demonstrated that 
corticosteroids reduce mortality and change 
outcomes significantly.14 Trivedi et al. found that 
mortality was higher in patients with pulmonary 
involvement who did not receive steroids and 
concluded that high dose glucocorticoids should be 
given as early as possible after the onset of dyspnoea 
to all the patients with pulmonary involvement.17 
Our patient received methylprednisolone, which 
would have influenced the recovery. Not only that, 
since the radiological lesions persisted, oral steroids 
were continued leading to a total resolution. This 
highlights the need to use steroids for a longer time 
to prevent post-ARDS lung fibrosis.
Conclusion
In this case, the administration of broad-spectrum 
antibiotics, mechanical ventilation, early supportive 
care, and the administration of corticosteroids led 
to clinical improvement and complete recovery. The 
clinical response suggests the utility of meropenem 
and moxifloxacin against Leptospira and underlines 
the need for the use of corticosteroids in cases of 
pulmonary involvement. 
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